As a support, both TIS and CYT gene signatures, associated with the identified Im-Clus, probe a good correlation with predictive effects of immunotherapy (anti PD-L1 response) in other tumors (melanoma, head and neck and gastric cancer) [18,20,89]. Here, CD274 is linked to melanoma.